‘A heaven for clinical trials, a hell for India’: Court orders government to regulate drugs testing by international pharmaceutical companies

Court orders government to regulate medical testing amid fears over industry’s safety


India’s highest court has given the government a month to come up with a plan to tighten regulations for clinical trials of new drugs – firing a warning shot at an industry that judges said has become a “hell for India”.

Amid claims that Indian citizens are being used as “guinea pigs” in an industry worth an estimated £310m a year, the Supreme Court told the government that no trials for new drugs should go ahead until a “mechanism is put in place to monitor them”. It said the health ministry should meet with regional officials within four weeks to discuss “strengthening the regulation of clinical trials”.

In recent years, India has emerged as one of the main locations for clinical trials by British, American and European pharmaceutical companies, looking for places to test new drugs and medicines. Hundreds of trials may be taking place at any one time.

But campaigners believe lax regulations have created a situation in India where those participating in the trials often have little idea about what they are doing. When things do go wrong, the authorities are slow to admit mistakes or to pay compensation. According to the Press Trust of India the Supreme Court bench, headed by Mr Justice RM Lodha, also called on the government to explain how it had approved 162 international trials to which it gave the go ahead between 3 July and 31 August  this year. The government said it would suspend approval for these trials.

“We have asked the government for the details of the trials they have approved and how these trials have benefited India,” said Amulya Nidhi, of an Indian NGO, Swasthya Adhikar Manch, which had filed a legal action before the court.

Campaigners say many of the clinical trials that are carried out in India do not meet international standards. An investigation in 2011 carried out by The Independent highlighted the recruitment of hundreds of tribal girls for a study without parental consent, the use by drug companies of survivors of the world’s worst poisonous gas disaster without proper informed consent and tests carried out by doctors in the city of Indore that a police investigation found violated ethical guidelines.

Pushed by campaigners, the courts and the Indian authorities have slowly been acting to tighten regulations.

This summer, the Supreme Court claimed the government was in a “deep slumber” over the danger of clinical trials. Judge Lodha said that while foreign companies were treating India as a “heaven for clinical trials, it is proving hell for India”.

Just how many people may have been killed or seriously harmed by clinical trials remains uncertain. The government has testified that between 2005-2012, around 2,644 people died during clinical trials for new drugs, of which 80 deaths were directly attributed to the items tested. A further 500 suffered serious adverse reactions.

But campaigners say because it is often the doctors involved in the trials who have to determine whether or not the drug is responsible for a fatality, figures can sometimes be skewed.

Earlier this month, a parliamentary panel seriously condemned a trial for a drug against cervical cancer. The 2010 trials were carried out in conjunction with the state government of Andhra Pradesh and were led by a US-based NGO, Path, which received millions of dollars from the Bill and Melinda Gates Foundation. Seven people died following the trial of two drugs, one produced by the US company Merck and another by GlaxoSmithKline.

Investigators found no convincing evidence that the seven young women died from the drug but the parliamentary panel found the trials had failed to obtain consent from the parents of the hundreds of tribal girls involved in the tests. It said Path was being used as a tool by foreign drug companies who wanted their products taken up by the federal government.

In a statement about the report, Path said: “We strongly disagree with the findings, conclusions and tone of the released report and its disregard of the evidence and facts.”

Industry estimates have suggested that the clinical trials industry in India could grow to £600m by 2016. But a recent flurry of interest by the courts appears to have spooked international drug firms.

It has been reported that as much as £100m of business could be lost this year because of uncertainty about the regulation environment.

“This has been a year of a lot of uncertainty in the clinical research industry,” Suneela Thatte, president of the Indian Society for Clinical Research, told the Mint newspaper. “This has eroded the confidence of Indian and global bio-pharma companies, research and teaching institutions and not-for-profit organisations in doing clinical research in India.”

Reports suggest up to 40 trials involving the US National Institutes of Health have been put on hold.

In a statement, a spokeswoman for the Washington-based NIH, said: “Because of the uncertainties posed by the new requirements, NIH and some grantees have suspended new patient enrolment for some of its ongoing interventional trials.  Some NIH-funded trials and other planned activities have been postponed pending clarification of the new regulations.”

Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Doctors - Dubai - High "Tax Free" Earnings

£96000 - £200000 per annum: Recruitment Genius: Looking for a better earning p...

Recruitment Genius: PHP Developer

£32000 - £36000 per annum: Recruitment Genius: A rapidly expanding company in ...

Recruitment Genius: PA

Negotiable: Recruitment Genius: A PA is required to join a leading provider of...

Recruitment Genius: Car Sales Executive - Franchised Main Dealer

£30000 - £40000 per annum: Recruitment Genius: This is a great opportunity for...

Day In a Page

Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

Isis stands strong as its numerous enemies fail to find a common plan to defeat it

The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

Virtual reality: Seeing is believing

Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
Homeless Veterans appeal: MP says Coalition ‘not doing enough’

Homeless Veterans appeal

MP says Coalition ‘not doing enough’ to help
Larry David, Steve Coogan and other comedians share stories of depression in new documentary

Comedians share stories of depression

The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
Has The Archers lost the plot with it's spicy storylines?

Has The Archers lost the plot?

A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
English Heritage adds 14 post-war office buildings to its protected lists

14 office buildings added to protected lists

Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Scientists unearthed the cranial fragments from Manot Cave in West Galilee
World War Z author Max Brooks honours WW1's Harlem Hellfighters in new graphic novel

Max Brooks honours Harlem Hellfighters

The author talks about race, legacy and his Will Smith film option to Tim Walker
Why the league system no longer measures up

League system no longer measures up

Jon Coles, former head of standards at the Department of Education, used to be in charge of school performance rankings. He explains how he would reform the system
Valentine's Day cards: 5 best online card shops

Don't leave it to the petrol station: The best online card shops for Valentine's Day

Can't find a card you like on the high street? Try one of these sites for individual, personalised options, whatever your taste
Diego Costa: Devil in blue who upsets defences is a reminder of what Liverpool have lost

Devil in blue Costa is a reminder of what Liverpool have lost

The Reds are desperately missing Luis Suarez, says Ian Herbert
Ashley Giles: 'I'll watch England – but not as a fan'

Ashley Giles: 'I'll watch England – but not as a fan'

Former one-day coach says he will ‘observe’ their World Cup games – but ‘won’t be jumping up and down’
Greece elections: In times like these, the EU has far more dangerous adversaries than Syriza

Greece elections

In times like these, the EU has far more dangerous adversaries than Syriza, says Patrick Cockburn
Holocaust Memorial Day: Nazi victims remembered as spectre of prejudice reappears

Holocaust Memorial Day

Nazi victims remembered as spectre of prejudice reappears over Europe
Fortitude and the Arctic attraction: Our fascination with the last great wilderness

Magnetic north

The Arctic has always exerted a pull, from Greek myth to new thriller Fortitude. Gerard Gilbert considers what's behind our fascination with the last great wilderness